The Association Between Increased Body Mass Index and Failure of Infliximab Treatment for Inflammatory Bowel Disease

被引：0
|
作者：
Tow, Clara Y.
Schneider, Yecheskel
Rosen, Melissa H.
Bosworth, Brian P.
机构：
来源：
GASTROENTEROLOGY | 2013年 / 144卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S439 / S439
页数：1
相关论文
共 50 条
  • [21] The association of infliximab trough levels with disease activity in pediatric inflammatory bowel disease
    Hoekman, Daniel R.
    Brandse, Johannan F.
    de Meij, Tim G.
    Hummel, Thalia Z.
    Lowenberg, Mark
    Benninga, Marc A.
    D'Haens, Geert R.
    Kindermann, Angelika
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2015, 50 (09) : 1110 - 1117
  • [22] Body Mass Index and Smoking Affect Thioguanine Nucleotide Levels in Inflammatory Bowel Disease
    Poon, Shi Sum
    Asher, Rebecca
    Jackson, Richard
    Kneebone, Andrew
    Collins, Paul
    Probert, Chris
    Dibb, Martyn
    Subramanian, Sreedhar
    JOURNAL OF CROHNS & COLITIS, 2015, 9 (08): : 640 - 646
  • [23] The impact of race and ethnicity on the association between body mass index and inflammatory markers
    Wee, Christina C.
    Mukamal, Kenneth J.
    Davis, Roger B.
    Huang, Annong
    McCarthy, Ellen P.
    Mittleman, Murray A.
    CIRCULATION, 2007, 115 (08) : E221 - E221
  • [24] Safety of infliximab treatment in pediatric patients with inflammatory bowel disease
    Scarbrough, M
    Calabro, C
    Carpenter, E
    Bendorf, K
    Friesen, CA
    Roberts, CC
    Daniel, JF
    Hodge, C
    GASTROENTEROLOGY, 2003, 124 (04) : A519 - A519
  • [25] Clinical Pharmacokinetics and Pharmacodynamics of Infliximab in the Treatment of Inflammatory Bowel Disease
    Hemperly, Amy
    Vande Casteele, Niels
    CLINICAL PHARMACOKINETICS, 2018, 57 (08) : 929 - 942
  • [26] Adherence to Infliximab Treatment in a Pediatric Inflammatory Bowel Disease Cohort
    Vitale, David S.
    Greenley, Rachel N.
    Lerner, Diana G.
    Mavis, Alisha M.
    Werlin, Steven L.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2015, 61 (04): : 408 - 410
  • [27] Autoimmune hepatitis following treatment with infliximab for inflammatory bowel disease
    van Casteren-Messidoro, Chiara
    Prins, Gerrie
    van Tilburg, Antonie
    Zelinkova, Zuzana
    Schouten, Joeffrey
    de Man, Rob
    JOURNAL OF CROHNS & COLITIS, 2012, 6 (05): : 630 - 631
  • [28] Infliximab: A Review of Its Use in the Treatment of Inflammatory Bowel Disease
    Marzo, Manuela
    Felice, Carla
    Rapaccini, Gian Lodovico
    Guidi, Luisa
    Armuzzi, Alessandro
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2011, 3 : 15 - 29
  • [29] Safety of infliximab treatment in pediatric patients with inflammatory bowel disease
    Friesen, CA
    Calabro, C
    Christenson, K
    Carpenter, E
    Welchert, E
    Daniel, JF
    Haslag, S
    Roberts, CC
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2004, 39 (03): : 265 - 269
  • [30] Balancing the risks and benefits of infliximab in the treatment of inflammatory bowel disease
    Sandborn, WJ
    Loftus, EV
    GUT, 2004, 53 (06) : 780 - 782
12345